samedan logo
 
 
spacer
home > directory > Waters Corporation
PHARMACEUTICAL INDUSTRY DIRECTORY

Waters Corporation

Waters Corporation

Waters Corporation, the premium brand in the analytical instruments industry since 1958, creates business advantages for laboratory-dependent organizations by delivering practical and sustainable scientific innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.  Bringing keen understanding and deep experience to those responsible for laboratory infrastructure and performance, Waters helps customers make profound discoveries, optimize lab operations, deliver product performance and ensure regulatory compliance.  Pioneering a connected portfolio of separations and analytical science, laboratory informatics, mass spectrometry as well as thermal analysis, Waters’ technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

1.800.252.4752
www.waters.com
34 Maple Street Milford, MA 01757-3696
 
Print this page
Send to a friend
spacer

Member login

E-mail address:

Password:
Remember me

Industry Events

EMBALLAGE 2008. World Packaging Exhibition

16-21 November 2008, Paris-Nord Villepinte - France

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 
News and Press Releases

PFIZER PRESENTS OVERALL SURVIVAL DATA FOR SUTENT™ VERSUS INTERFERON-ALFA

Chicago, 31 May 2008- Results from a landmark study have shown that sunitinib (SUTENT™) has demonstrated overall survival greater than two years in patients with metastatic renal cell carcinoma (mRCC), also known as advanced kidney cancer.  This is the first time overall survival data representing more than two years has been achieved in the first line setting of mRCC, which is clinically meaningful and reflective of major advances in the treatment of kidney cancer. 
More info >>

 
©2000-2007 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement